Morpholino

MO2-esr2b

ID
ZDB-MRPHLNO-140605-3
Name
MO2-esr2b
Previous Names
None
Target
Sequence
5' - AGCTCATGCTGGAGAACACAAGAGA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-esr2b
No data available
Phenotype
Phenotype resulting from MO2-esr2b
No data available
Phenotype of all Fish created by or utilizing MO2-esr2b
Phenotype Fish Conditions Figures
liver GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 17-alpha-Ethinylestradiol Fig. 3 from Moreman et al., 2018
trunk somite GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 17-alpha-Ethinylestradiol Fig. 3 from Moreman et al., 2018
trunk somite GFP expression increased amount, abnormal u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: bisphenol A Fig. 3 from Moreman et al., 2018
liver GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: bisphenol A Fig. 3 from Moreman et al., 2018
liver GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 4-Methyl-2,4-bis-(p-hydroxyphenyl)pent-1-ene Fig. 3 from Moreman et al., 2018
trunk somite GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 4-Methyl-2,4-bis-(p-hydroxyphenyl)pent-1-ene Fig. 3 from Moreman et al., 2018
caudal fin somite GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 17-alpha-Ethinylestradiol Fig. 3 from Moreman et al., 2018
heart GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 17-alpha-Ethinylestradiol Fig. 3 from Moreman et al., 2018
heart GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: bisphenol A Fig. 3 from Moreman et al., 2018
caudal fin somite GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: bisphenol A Fig. 3 from Moreman et al., 2018
caudal fin somite GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 4-Methyl-2,4-bis-(p-hydroxyphenyl)pent-1-ene Fig. 3 from Moreman et al., 2018
heart GFP expression amount, ameliorated u300Tg/u300Tg; uex3Tg/uex3Tg + MO2-esr2b + MO5-esr2a chemical treatment by environment: 4-Methyl-2,4-bis-(p-hydroxyphenyl)pent-1-ene Fig. 3 from Moreman et al., 2018
Citations